Department of Insurance; to meet with stakeholders to explore best practices in the medical surveillance of patients after primary therapy for breast cancer and to provide any recommendations; urge
Impact
The resolution highlights the growing need for evidence-based surveillance protocols post-cancer treatment. It emphasizes the medical necessity and potential cost-effectiveness of different imaging techniques, like mammograms and MRIs, especially when patients are asymptomatic. By advocating for a more structured approach to patient monitoring, SR907 seeks to influence state healthcare policies, potentially improving outcomes for breast cancer survivors through systematic follow-up care.
Summary
Senate Resolution 907 (SR907) addresses the importance of medical surveillance for patients who have undergone primary therapy for breast cancer. It urges the Department of Insurance, in collaboration with the Department of Community Health, to convene with various stakeholders including healthcare providers, cancer survivors, and insurers. The goal is to explore best practices in monitoring these patients after their initial treatment, assessing methods for early detection of local recurrence and managing potential therapy-related diseases.
Contention
Debate around SR907 includes discussions about the financial implications of routine surveillance practices. While some healthcare professionals support extensive follow-up imaging as crucial for early detection, others raise concerns about the necessity and cost-effectiveness of such procedures. This tension reflects a broader discourse in the medical community about balancing proactive care with the financial burden of healthcare services on patients and insurers.
Requires hospitals to provide breast cancer patients with information concerning reconstructive surgery; prohibits certain provisions in managed care plan contracts.
Requires hospitals to provide breast cancer patients with information concerning reconstructive surgery; prohibits certain provisions in managed care plan contracts.
Insurance: health insurers; coverage for examinations and medications related to breast cancer; provide for. Amends sec. 3406d of 1956 PA 218 (MCL 500.3406d).
Insurance; certain health benefit policies to cover an annual chest imaging test for a covered person who has undergone a mastectomy or other cancer treatment; provide
Requires health insurance coverage of scalp cooling systems in connection with cancer chemotherapy treatment; requires physicians to inform patients of scalp cooling therapy.
Requires health insurance coverage of scalp cooling systems in connection with cancer chemotherapy treatment; requires physicians to inform patients of scalp cooling therapy.
Urging the Congress of the United States to establish policies that would provide greater access to blood transfusions for hospice patients with blood cancer.